Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specificall…
An institutional-grade, numbers-driven thesis on PMI — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 18, 2026, TradersQuant's model rates Picard Medical, Inc. (PMI) 40/100 with a 12-month base-case forecast of $1.76 — -50.0% versus the current price of $3.52. Picard Medical, Inc. trades at $3.52 in the Healthcare sector, with a market capitalisation of $361.5M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for PMI is $1.76, implying -50.0% versus the current price. The model's 12-month scenario range runs from $1.44 (bear) to $2.02 (bull), with a base case of $1.76.
On the fundamentals, Picard Medical shows a P/E of -0.2, trailing revenue of $4.9M, revenue growth of +12.5% YoY. This page also tracks PMI's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
PMI currently carries a TradersQuant composite score of 40/100, which we read as a cautious signal. The Wall-Street analyst consensus is "Hold". Our 12-month price target of $1.76 implies -50.0% from $3.52. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for PMI is $1.76, about -50.0% versus the latest price of $3.52. Consensus is based on 1 analysts.
TradersQuant's 12-month model forecast for PMI is a base case of $1.76, ranging from $1.44 (bear) to $2.02 (bull), an expected return of -50.0%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for PMI over the next 12 months is $1.76 in the base case (bear $1.44, bull $2.02), versus today's price of $3.52. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for PMI — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates PMI's fair value at $4.21, implying +19.7% of expected upside versus the current price.
Picard Medical does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
